Загрузка...
SUN-179 Prolonged Hypoglycemia from Insulin Degludec
Prolonged Hypoglycemia from Insulin Degludec Background: Patients with type 2 diabetes treated with insulin degludec compared with insulin glargine had a reduced risk of overall symptomatic hypoglycemia (1). This is primarily due to former’s long half-life (25 hours) and lack of trough lev...
Сохранить в:
| Опубликовано в: : | J Endocr Soc |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Endocrine Society
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553236/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-179 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|